TMX-202-based foam formulation (Telormedix/Foamix)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTMX-202-based foam formulation (Telormedix/Foamix)
Drug Alias NameTOSCA project (Telormedix/Foamix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsKeratosisSkin NeoplasmsCondylomata Acuminata
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTelormedix Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTelormedix SaFoamix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsKeratosisSkin NeoplasmsCondylomata Acuminata

Other Information

ATC CodeN/A
Related LinksN/A